Group 1 - The company *ST Asia Pacific announced that its ninth board meeting was held on January 22, 2026, via communication voting [1] - The meeting reviewed the proposal regarding the expected daily related transactions for January to February 2026 [1]

证券代码：000691 证券简称：*ST亚太 公告编号：2026-013 甘肃亚太实业发展股份有限公司 3、根据《深圳证券交易所股票上市规则》及《公司章程》的有关规定，该 议案无需提交公司股东会审议。 （二）预计2026年1-2月日常关联交易类别和金额 关于2026年1-2月日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 （一）日常关联交易概述 甘肃亚太实业发展股份有限公司（以下简称"公司"）及子公司因日常生 产经营的需要，2026 年 1-2 月预计与关联方河北亚诺生物科技集团股份有限公 司（以下简称"亚诺生物集团"）及其控股子公司沧州临港亚诺生物医药有限 公司、河北尚都环境科技有限公司、石家庄信诺化工有限公司、乌海市兰亚化 工有限责任公司发生的日常关联交易金额不超过 2,219 万元。 上述 2026 年 1-2 月日常关联交易履行的审议程序： 1、公司于 2026 年 1 月 22 日召开第九届董事会第二十二次会议，审议通过 了《关于 2026 年 1-2 月日常关联交易预计的议案》，鉴于上述关联方均为公 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 二、董事会会议审议情况 证券代码：000691 证券简称：*ST亚太 公告编号：2026-012 甘肃亚太实业发展股份有限公司 第九届董事会第二十二次会议决议公告 甘肃亚太实业发展股份有限公司（以下简称"公司"）于 2026 年 1 月 19 日以电话、电子邮件方式发出会议通知，并于 2026 年 1 月 22 日以通讯表决的 方式召开第九届董事会第二十二次会议。本次会议应出席董事 9 名，实际出席 董事 9 名，由董事长陈志健先生主持。本次会议的召开符合《中华人民共和国 公司法》、《中华人民共和国证券法》、《深圳证券交易所股票上市规则》和 《公司章程》的有关规定。 审议通过了《关于 2026 年 1-2 月日常关联交易预计的议案》 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的《关于 2026 年 1-2 月日常关联交易预计的公告》（公告编号：2026-013）。 公司第九届董事会第二十二次会议决议。 特此公告。 甘肃亚太实业发展股份有限公司 董事会 202 ...

Core Viewpoint - As of January 22, a total of 15 ST stocks have announced their annual performance forecasts, with 1 company expecting profit, 7 companies expecting reduced losses, and 5 companies expecting losses [1] Group 1: Performance Forecasts - The company with the highest expected loss is ST Changyuan, with an estimated loss of 1.08 billion yuan, followed by ST Saiwei and ST Dongshi, with expected losses of 720 million yuan and 600 million yuan respectively [1] - The detailed performance forecasts for ST stocks include: - *ST Huawei: Expected profit of 175 million yuan to 145 million yuan, with a year-to-date change of +6.28% [1] - ST Yuanzhi: Expected profit of 110 million yuan to 90 million yuan, with a year-to-date change of +16.82% [1] - *ST Tianze: Expected profit of 30 million yuan to 27 million yuan, with a year-to-date change of +7.96% [1] - ST Hongda: Expected reduced loss of 16 million yuan to 24 million yuan, with a year-to-date change of +9.40% [1] - *ST Yatai: Expected reduced loss of 28.39 million yuan to 51.46 million yuan, with a year-to-date change of +27.80% [1] - ST Ningke: Expected reduced loss of 75 million yuan to 100 million yuan, with a year-to-date change of -6.02% [1] - *ST Huawang: Expected reduced loss of 180 million yuan to 240 million yuan, with a year-to-date change of -6.46% [1] - *ST Changyao: Expected reduced loss of 350 million yuan to 520 million yuan, with a year-to-date change of -26.44% [1] - *ST Zhanggu: Expected reduced loss of 450 million yuan to 550 million yuan, with a year-to-date change of -6.57% [1] - ST Huayang: Expected loss of 590 million yuan to 700 million yuan, with a year-to-date change of +4.75% [1] - ST Dongshi: Expected reduced loss of 600 million yuan to 700 million yuan, with a year-to-date change of +2.93% [1] - ST Saiwei: Expected loss of 720 million yuan to 1.02 billion yuan, with a year-to-date change of +44.61% [1] - ST Changyuan: Expected loss of 1.08 billion yuan to 1.45 billion yuan, with a year-to-date change of +24.93% [1] - *ST Yanshi: Expected loss, no specific figures provided, with a year-to-date change of -22.76% [1] - *ST Wanfang: Expected loss, no specific figures provided, with a year-to-date change of -24.79% [1]

Group 1 - The company, Gansu Asia-Pacific Industrial Development Co., Ltd., expects a negative net profit for the fiscal year 2025, marking the first accounting year after the implementation of financial delisting risk warning [1] - The performance forecast period is from January 1, 2025, to December 31, 2025, with the expected net profit being negative [1] - The company has communicated with the accounting firm regarding the performance forecast, and there are no disagreements between the company and the accounting firm on this matter [1][2] Group 2 - The increase in operating income and net profit compared to the same period last year is primarily due to the recovery of the industry cycle and the rebound in demand for pesticides and pharmaceutical intermediates [2] - The equity attributable to shareholders of the listed company has significantly increased compared to the same period last year, mainly due to the completion of bankruptcy reorganization and receipt of reorganization investment funds, as well as debt exemptions and cash donations [2] Group 3 - The company’s stock has been subject to delisting risk warning since April 30, 2025, due to a negative net asset value as of the end of the 2024 fiscal year [8][9] - If the company encounters specific conditions outlined in the Shenzhen Stock Exchange listing rules during the 2025 fiscal year, it may face termination of its stock listing [9][10] - The company has received a cash donation of 73 million yuan from the reorganization investor and a debt exemption of 75 million yuan from its former controlling shareholder, which are aimed at alleviating debt pressure and enhancing operational capability [13][14]

Group 1 - The company *ST Asia Pacific (000691.SZ) expects a net loss of between 51.46 million to 28.39 million yuan for 2025, with a non-recurring net loss projected between 43.95 million to 24.25 million yuan, and operating revenue estimated to be between 416.80 million to 599.15 million yuan [1] - The increase in operating revenue and net profit compared to the same period last year is primarily attributed to the recovery of the industry cycle and the rebound in demand for pesticides and pharmaceutical intermediates [1] - The equity attributable to shareholders of the listed company has significantly increased compared to the same period last year, mainly due to the completion of bankruptcy reorganization, receipt of reorganization investment funds, debt exemptions, and cash donations [1]

Core Viewpoint - The company expects revenue for 2025 to be between 416.80 million and 599.15 million yuan, a decrease from 443.01 million yuan in the same period last year, while net profit attributable to shareholders is projected to be between -51.46 million and -28.39 million yuan, representing a growth of 51.01% to 72.97% compared to the previous year [1] Revenue and Profit Outlook - The anticipated revenue range for 2025 is 416.80 million to 599.15 million yuan, down from 443.01 million yuan in the previous year [1] - The projected net profit attributable to shareholders is expected to be between -51.46 million and -28.39 million yuan, indicating a significant improvement of 51.01% to 72.97% year-on-year [1] Industry Context - The growth in revenue and net profit is primarily attributed to the recovery of the industry cycle and an increase in demand [1] Financial Health - The company is projected to have a negative net asset value by the end of 2024, and its stock is under delisting risk warning [1] - If the company encounters related circumstances in 2025, it may face the risk of termination of its listing [1]

证券代码：000691 证券简称：*ST亚太 公告编号：2026-011 甘肃亚太实业发展股份有限公司 关于公司股票可能被终止上市的风险提示公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、甘肃亚太实业发展股份有限公司（以下简称"公司"）于2025年4月29 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于公司股票交易被实施退市 风险警示暨股票停牌的公告》（公告编号：2025-037），公司2024年度经审计的 期末净资产为负值，根据《深圳证券交易所股票上市规则》第9.3.1条第一款第（二） 项的规定，公司股票交易自2025年4月30日起被实施退市风险警示。若公司2025 年度出现《深圳证券交易所股票上市规则》第9.3.12条规定的相关情形，公司股 票将面临被终止上市的风险。 2、根据《深圳证券交易所股票上市规则》第9.3.6条"上市公司因触及本规 则第9.3.1条第一款第一项至第三项情形，其股票交易被实施退市风险警示后，应 当在其股票交易被实施退市风险警示当年会计年度结束后一个月内，披露股票可 能被终止上市的风险提示公告， ...

2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：股票交易已被实施财务类退市风险警示后的首个会计年度、预计 净利润为负值 （1）以区间数进行业绩预告的 单位：万元 | 项 | 目 | | 本会计年度 | | | 上年同期 | | --- | --- | --- | --- | --- | --- | --- | | 利润总额 | | | -4,816.09 | ～ | -2,657.15 | -10,882.94 | | | | 比上年同期增长 | 55.75% | ～ | 75.58% | | | 归属于上市公司股 | | | -5,145.81 | ～ | -2,839.07 | -10,503.48 | | 东的净利润 | | 比上年同期增长 | 51.01% | ～ | 72.97% | | | 扣除非经常性损益 | | | -4,395.38 | ～ | -2,425.04 | -10,672.93 | ...

Core Viewpoint - *ST Asia Pacific (sz000691) experienced a limit down on January 20, 2026, with a price of 9.05 yuan, a decline of 4.83%, and a total market capitalization of 4.398 billion yuan [1] Group 1: Company Financials and Risks - The company has a negative net asset value as of 2024, and if it does not turn a profit by 2025, it faces the risk of delisting [2] - A high percentage of shareholder pledges is evident, with a total pledge ratio of 79.22% among concerted actors, indicating significant financial pressure on shareholders [2] - The company has completed its restructuring plan, but there remains a risk of failure in executing this plan, which could lead to bankruptcy [2] Group 2: Business Transformation Challenges - The transition from traditional chemicals to electronic chemicals and military industries presents technical and management challenges, with uncertain outcomes for the transformation [2] - The company's involvement in fine chemicals and military sectors is subject to market sentiment, which can be influenced by various factors affecting the overall performance of these sectors [2] Group 3: Market Conditions and Stock Performance - A significant number of restricted shares, totaling 63.3596 million shares (13.07% of total shares), are set to be released on January 12, 2027, which may increase supply pressure on the stock price [2] - The stock price may face downward pressure due to multiple negative factors, especially if there is insufficient upward momentum in previous price movements [2]